<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Optic Neuritis - Optic Nerve Inflammation Guide | Vision Health Portal</title>
    <meta name="description"
        content="Comprehensive guide to optic neuritis: optic nerve inflammation often linked to multiple sclerosis, vision loss, eye pain with movement, MRI diagnosis, and steroid treatment.">
    <link rel="stylesheet" href="../style.css">
    <link rel="stylesheet" href="disease-style.css">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.0.0/css/all.min.css">
</head>

<body>
    <header>
        <a href="../index.html" class="logo">
            <i class="fas fa-eye"></i> VisionHealth
        </a>
        <nav>
            <ul>
                <li><a href="../index.html">Home</a></li>
                <li><a href="../tests/index.html">Vision Tests</a></li>
                <li><a href="../innovations.html">Innovations</a></li>
            </ul>
        </nav>
    </header>

    <div class="disease-hero">
        <h1>Optic Neuritis</h1>
        <p>Inflammation of the Optic Nerve</p>
        <span class="category"><i class="fas fa-tag"></i> Optic Nerve Disorder</span>
    </div>

    <div class="disease-content-wrapper">
        <aside class="toc">
            <h3>Contents</h3>
            <ul>
                <li><a href="#overview">Overview</a></li>
                <li><a href="#causes">Causes & MS Link</a></li>
                <li><a href="#symptoms">Symptoms</a></li>
                <li><a href="#diagnosis">Diagnosis</a></li>
                <li><a href="#treatment">Treatment</a></li>
                <li><a href="#prognosis">Prognosis & Recovery</a></li>
                <li><a href="#ms-risk">Multiple Sclerosis Risk</a></li>
                <li><a href="#recurrence">Recurrence</a></li>
                <li><a href="#when-to-see">When to See a Doctor</a></li>
            </ul>
        </aside>

        <main class="disease-content">
            <section id="overview">
                <h2>What Is Optic Neuritis?</h2>
                <p>Optic neuritis is inflammation of the optic nerve—the cable of nerve fibers that transmits visual
                    information from the eye to the brain. When the optic nerve becomes inflamed, the protective myelin
                    sheath surrounding the nerve fibers is damaged (demyelination), disrupting signal transmission and
                    causing vision loss. Optic neuritis typically affects one eye and presents with sudden vision loss,
                    eye pain (especially with eye movement), and decreased color vision.</p>

                <p>The condition is most commonly associated with <strong>multiple sclerosis (MS)</strong>, an
                    autoimmune disease affecting the brain and spinal cord. For many people, optic neuritis is the first
                    sign of MS, though it can also occur as an isolated event or be linked to other inflammatory or
                    infectious causes. While optic neuritis can be alarming, most patients experience significant vision
                    recovery within weeks to months, though subtle deficits may persist.</p>

                <div class="key-facts">
                    <h3><i class="fas fa-info-circle"></i> Key Facts About Optic Neuritis</h3>
                    <ul>
                        <li><strong>Optic nerve inflammation:</strong> Damages myelin coating, disrupting visual signal
                            transmission.</li>
                        <li><strong>Sudden vision loss:</strong> Develops over hours to days; usually one eye.</li>
                        <li><strong>Eye pain with movement:</strong> Hallmark symptom; pain worsens when moving eyes.
                        </li>
                        <li><strong>Strongly linked to MS:</strong> 50% of patients with MS experience optic neuritis;
                            conversely, 50% of optic neuritis patients eventually develop MS.</li>
                        <li><strong>Young adults:</strong> Peak age 20-40 years; more common in women.</li>
                        <li><strong>Usually recovers:</strong> Vision typically improves spontaneously over 4-12 weeks.
                        </li>
                        <li><strong>Steroids may speed recovery:</strong> IV corticosteroids don't improve final vision
                            but hasten recovery.</li>
                        <li><strong>MRI important:</strong> Brain MRI assesses MS risk.</li>
                    </ul>
                </div>

                <p>Understanding optic neuritis is crucial for recognizing early MS symptoms and managing vision
                    recovery.</p>
            </section>

            <section id="causes">
                <h2>Causes and Multiple Sclerosis Link</h2>

                <h3>Demyelinating Diseases (Most Common)</h3>

                <h4>Multiple Sclerosis (MS)</h4>
                <ul>
                    <li><strong>Strongest association:</strong> Optic neuritis often first manifestation of MS</li>
                    <li><strong>Statistics:</strong>
                        <ul>
                            <li>About 50% of MS patients have optic neuritis at some point</li>
                            <li>About 50% of isolated optic neuritis patients develop MS within 15 years</li>
                        </ul>
                    </li>
                    <li>MS is autoimmune disease where immune system attacks myelin in central nervous system</li>
                    <li>Causes scattered lesions (plaques) in brain and spinal cord</li>
                </ul>

                <h4>Neuromyelitis Optica (NMO) / NMO Spectrum Disorder (NMOSD)</h4>
                <ul>
                    <li>Severe autoimmune disease affecting optic nerves and spinal cord</li>
                    <li>Often bilateral and more severe than typical MS-related optic neuritis</li>
                    <li>Worse outcomes than MS-associated optic neuritis</li>
                    <li>Requires different treatment than MS</li>
                    <li>Aquaporin-4 antibody often positive</li>
                </ul>

                <h4>Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated Disease</h4>
                <ul>
                    <li>Recently recognized autoimmune condition</li>
                    <li>Optic neuritis often bilateral</li>
                    <li>Generally better prognosis than NMO</li>
                </ul>

                <h3>Infectious Causes</h3>
                <ul>
                    <li><strong>Viral infections:</strong> Herpes, varicella-zoster, CMV, HIV</li>
                    <li><strong>Bacterial:</strong> Lyme disease, syphilis, tuberculosis, cat-scratch disease</li>
                    <li><strong>Fungal or parasitic:</strong> Rare</li>
                    <li>More common in children or immunocompromised individuals</li>
                </ul>

                <h3>Other Inflammatory/Autoimmune Causes</h3>
                <ul>
                    <li><strong>Sarcoidosis:</strong> Inflammatory disease affecting multiple organs</li>
                    <li><strong>Lupus (SLE)</strong></li>
                    <li><strong>Vasculitis</strong></li>
                    <li><strong>Post-vaccination or post-viral:</strong> Immune response triggered after infection or
                        vaccination (rare)</li>
                </ul>

                <h3>Idiopathic (Unknown Cause)</h3>
                <ul>
                    <li>Some cases have no identifiable cause</li>
                    <li>May be isolated single episode</li>
                    <li>Lower MS risk if isolated</li>
                </ul>

                <h3>Risk Factors</h3>
                <ul>
                    <li><strong>Age:</strong> 20-40 years (peak incidence)</li>
                    <li><strong>Sex:</strong> Women affected 2-3 times more than men</li>
                    <li><strong>Race:</strong> More common in Caucasians</li>
                    <li><strong>Geography:</strong> Higher rates farther from equator (MS correlation)</li>
                    <li><strong>Genetics:</strong> Family history of MS increases risk</li>
                </ul>
            </section>

            <section id="symptoms">
                <h2>Recognizing the Symptoms</h2>

                <div class="symptoms-grid">
                    <div class="symptom-card">
                        <h4><i class="fas fa-eye-slash"></i> Sudden Vision Loss</h4>
                        <p>Vision loss develops over hours to days; ranges from mild blurring to severe loss; usually
                            one eye (unilateral).</p>
                    </div>

                    <div class="symptom-card">
                        <h4><i class="fas fa-exclamation-circle"></i> Eye Pain with Movement</h4>
                        <p>Hallmark symptom: pain behind eye worsens with eye movements; 90% of patients experience
                            this.</p>
                    </div>

                    <div class="symptom-card">
                        <h4><i class="fas fa-palette"></i> Decreased Color Vision (Dyschromatopsia)</h4>
                        <p>Colors appear washed out, faded, or less vibrant; red especially affected; often out of
                            proportion to visual acuity loss.</p>
                    </div>

                    <div class="symptom-card">
                        <h4><i class="fas fa-lightbulb"></i> Flashing Lights (Phosphenes)</h4>
                        <p>Brief flashes of light with eye movement; caused by mechanical stimulation of inflamed nerve.
                        </p>
                    </div>

                    <div class="symptom-card">
                        <h4><i class="fas fa-adjust"></i> Decreased Brightness Perception</h4>
                        <p>Affected eye sees dimmer image compared to good eye; lights appear less bright.</p>
                    </div>

                    <div class="symptom-card">
                        <h4><i class="fas fa-sun"></i> Light Sensitivity</h4>
                        <p>Photophobia though not as severe as in other eye conditions.</p>
                    </div>
                </div>

                <h3>Vision Loss Characteristics</h3>
                <ul>
                    <li><strong>Severity:</strong> Highly variable—mild blur to no light perception</li>
                    <li><strong>Onset:</strong> Peaks over days to 1-2 weeks</li>
                    <li><strong>Unilateral:</strong> Typically one eye (bilateral suggests NMO or MOG)</li>
                    <li><strong>Central vision:</strong> Usually affects central vision most</li>
                </ul>

                <h3>Eye Pain</h3>
                <ul>
                    <li>Present in ~90% of cases</li>
                    <li>Typically precedes or accompanies vision loss</li>
                    <li>Worsens with eye movement (looking side to side, up/down)</li>
                    <li>Described as dull ache or pressure behind eye</li>
                    <li>May radiate to forehead or temple</li>
                    <li>Resolves within days even if vision loss persists</li>
                </ul>

                <h3>Uhthoff's Phenomenon</h3>
                <ul>
                    <li>Worsening of symptoms with heat or exercise</li>
                    <li>Vision temporarily deteriorates when body temperature rises</li>
                    <li>Improves with cooling</li>
                    <li>Seen in demyelinating diseases</li>
                </ul>

                <h3>What Optic Neuritis Usually Doesn't Cause</h3>
                <ul>
                    <li>Severe external eye redness (eye looks normal)</li>
                    <li>Double vision (that's other cranial nerves)</li>
                    <li>Complete permanent blindness (most recover substantial vision)</li>
                </ul>
            </section>

            <section id="diagnosis">
                <h2>Diagnosis</h2>

                <h3>Clinical History and Examination</h3>

                <h4>History</h4>
                <ul>
                    <li>Onset and progression of vision loss</li>
                    <li>Eye pain with movement?</li>
                    <li>Previous episodes of optic neuritis or neurological symptoms?</li>
                    <li>Family history of MS or autoimmune disease?</li>
                    <li>Recent infections or vaccinations?</li>
                </ul>

                <h4>Visual Acuity Testing</h4>
                <ul>
                    <li>Quantifies degree of vision loss</li>
                    <li>Range: 20/20 (mild) to no light perception (severe)</li>
                    <li>Baseline for tracking recovery</li>
                </ul>

                <h4>Color Vision Testing</h4>
                <ul>
                    <li>Ishihara plates or other color tests</li>
                    <li>Often significantly reduced even with relatively preserved acuity</li>
                    <li>Red desaturation test (Comparing red color brightness between eyes)</li>
                </ul>

                <h4>Pupil Examination - Relative Afferent Pupillary Defect (RAPD)</h4>
                <ul>
                    <li><strong>Swinging flashlight test:</strong> Classic finding</li>
                    <li>Affected eye's pupil dilates (instead of constricting) when light swung to it</li>
                    <li>Indicates optic nerve dysfunction</li>
                    <li>Present in vast majority of optic neuritis cases</li>
                </ul>

                <h4>Visual Field Testing</h4>
                <ul>
                    <li>Automated perimetry</li>
                    <li>Common patterns: Central scotoma (blind spot in center), arcuate defects</li>
                    <li>Helps assess severity and monitor recovery</li>
                </ul>

                <h4>Fundus Examination (Ophthalmoscopy)</h4>
                <ul>
                    <li><strong>Retrobulbar optic neuritis (most common, ~2/3 cases):</strong>
                        <ul>
                            <li>Optic disc appears NORMAL initially</li>
                            <li>Inflammation is behind the eye (in orbital portion of nerve)</li>
                            <li>"The patient sees nothing, and the doctor sees nothing"</li>
                        </ul>
                    </li>
                    <li><strong>Papillitis (~1/3 cases):</strong>
                        <ul>
                            <li>Optic disc swollen, hyperemic (red)</li>
                            <li>Inflammation at disc itself (visible portion of nerve)</li>
                            <li>May have hemorrhages near disc</li>
                        </ul>
                    </li>
                    <li>Later (weeks): Optic atrophy (pale disc) may develop</li>
                </ul>

                <h3>Imaging</h3>

                <h4>MRI of Brain and Orbits with Gadolinium (Essential)</h4>
                <p>Most important test:</p>
                <ul>
                    <li><strong>Optic nerve:</strong> Enhancement (brightening) of inflamed optic nerve on
                        gadolinium-enhanced sequences</li>
                    <li><strong>Brain lesions:</strong> White matter lesions indicate demyelination
                        <ul>
                            <li>Presence of brain lesions dramatically increases MS risk</li>
                            <li><strong>No brain lesions:</strong> ~25% risk of MS at 15 years</li>
                            <li><strong>2+ brain lesions:</strong> ~70% risk of MS at 15 years</li>
                        </ul>
                    </li>
                    <li>Helps differentiate MS from NMO (NMO has longer optic nerve lesions)</li>
                </ul>

                <h3>Blood Tests</h3>
                <ul>
                    <li><strong>NMO-IgG (Aquaporin-4 antibody):</strong> If NMO suspected</li>
                    <li><strong>MOG antibody:</strong> If MOG-associated disease suspected</li>
                    <li><strong>Infectious workup:</strong> If atypical features (especially in children)—Lyme,
                        syphilis, HIV, etc.</li>
                    <li><strong>Inflammatory markers:</strong> ESR, CRP, ANA, ACE (sarcoidosis) if systemic disease
                        suspected</li>
                </ul>

                <h3>Lumbar Puncture (Spinal Tap)</h3>
                <ul>
                    <li>Not always necessary for isolated optic neuritis</li>
                    <li>Performed if MS diagnosis uncertain</li>
                    <li>Looking for:
                        <ul>
                            <li>Oligoclonal bands (suggests MS)</li>
                            <li>Elevated IgG index</li>
                            <li>Infection (if suspected)</li>
                        </ul>
                    </li>
                </ul>

                <h3>Optical Coherence Tomography (OCT)</h3>
                <ul>
                    <li>Measures retinal nerve fiber layer (RNFL) thickness</li>
                    <li>Initially may be swollen, later becomes thin (atrophy)</li>
                    <li>Useful for monitoring and research</li>
                </ul>
            </section>

            <section id="treatment">
                <h2>Treatment</h2>

                <h3>Corticosteroids - Standard Treatment</h3>

                <h4>IV Methylprednisolone (High-Dose)</h4>
                <p>Based on Optic Neuritis Treatment Trial (ONTT):</p>
                <ul>
                    <li><strong>Regimen:</strong> 1 gram IV daily for 3-5 days, followed by oral prednisone taper
                        (typically 11 days)</li>
                    <li><strong>Effect:</strong>
                        <ul>
                            <li>Speeds visual recovery (get better faster)</li>
                            <li>Does NOT improve final visual outcome</li>
                            <li>Reduces MS risk in the first 2 years (after that, no difference)</li>
                        </ul>
                    </li>
                    <li><strong>When used:</strong> Severe vision loss, bilateral involvement, pain, patient preference
                        for faster recovery</li>
                    <li>Administered as outpatient infusion or hospitalized if severe</li>
                </ul>

                <h4>Oral Prednisone Alone - NOT Recommended</h4>
                <ul>
                    <li>ONTT showed oral prednisone alone (without IV steroids first) increased recurrence risk</li>
                    <li>Should not be used as sole treatment</li>
                </ul>

                <h3>Observation (No Treatment)</h3>
                <ul>
                    <li>Acceptable option for some patients</li>
                    <li>Vision typically recovers spontaneously</li>
                    <li>Final outcome similar to those treated with IV steroids</li>
                    <li>Recovery just takes longer (weeks-months)</li>
                    <li>Chosen if: Mild vision loss, improving already, patient preference, contraindications to
                        steroids</li>
                </ul>

                <h3>Treatment of Underlying Cause</h3>
                <ul>
                    <li><strong>NMO/NMOSD:</strong> High-dose IV steroids, sometimes plasma exchange; immunosuppressive
                        therapy to prevent relapses</li>
                    <li><strong>MOG-antibody disease:</strong> Steroids; may need longer taper to prevent relapses</li>
                    <li><strong>Infections:</strong> Appropriate antibiotic, antiviral, or antifungal</li>
                    <li><strong>Sarcoidosis:</strong> Steroids, sometimes immunosuppressants</li>
                </ul>

                <h3>MS Disease-Modifying Therapy (DMT)</h3>
                <ul>
                    <li>If brain MRI shows lesions (high MS risk), early DMT may be considered</li>
                    <li>Slows MS progression, reduces relapse rate</li>
                    <li>Options: interferons, glatiramer acetate, newer oral or infusion therapies</li>
                    <li>Decision made by neurologist in conjunction with patient</li>
                </ul>

                <h3>Plasma Exchange (Plasmapheresis)</h3>
                <ul>
                    <li>For severe cases not responding to steroids</li>
                    <li>NMO often requires this</li>
                    <li>Removes antibodies from blood</li>
                </ul>

                <h3>Supportive Care</h3>
                <ul>
                    <li>Pain management (NSAIDs usually sufficient; pain typically brief)</li>
                    <li>Patient education and reassurance</li>
                    <li>Low vision aids if severe persistent loss</li>
                </ul>
            </section>

            <section id="prognosis">
                <h2>Prognosis and Visual Recovery</h2>

                <h3>Natural History (ONTT Data)</h3>
                <ul>
                    <li><strong>Vision recovery:</strong> Begins within 2-3 weeks, continues over 4-12 weeks</li>
                    <li><strong>Final visual acuity:</strong>
                        <ul>
                            <li>20/40 or better in ~90-95% of patients by 1year</li>
                            <li>20/20 in ~70%</li>
                        </ul>
                    </li>
                    <li><strong>Complete recovery:</strong> Many recover to "normal" on chart but may have subtle
                        deficits:
                        <ul>
                            <li>Decreased contrast sensitivity</li>
                            <li>Reduced color vision</li>
                            <li>Visual field defects</li>
                            <li>Optic atrophy on exam</li>
                        </ul>
                    </li>
                </ul>

                <h3>Factors Affecting Recovery</h3>

                <h4>Better Prognosis:</h4>
                <ul>
                    <li>Mild initial vision loss</li>
                    <li>Younger age</li>
                    <li>Absence of disc swelling</li>
                    <li>Rapid initial improvement</li>
                </ul>

                <h4>Poorer Prognosis:</h4>
                <ul>
                    <li>Very poor initial vision (no light perception)</li>
                    <li>Severe disc swelling</li>
                    <li>NMO (worse than MS-associated)</li>
                    <li>Older age, male sex (slight correlation)</li>
                </ul>

                <h3>Residual Symptoms</h3>
                <ul>
                    <li><strong>Persistent subtle deficits:</strong> Even with 20/20 acuity</li>
                    <li><strong>Uhthoff's phenomenon:</strong> May persist; heat worsens vision temporarily</li>
                    <li><strong>Pulfrich phenomenon:</strong> Moving objects appear to follow curved path (due to
                        conduction delay in affected nerve)</li>
                </ul>

                <h3>Long-Term Optic Atrophy</h3>
                <ul>
                    <li>Optic disc becomes pale over months</li>
                    <li>Retinal nerve fiber layer thins (visible on OCT)</li>
                    <li>Permanent structural change even if vision good</li>
                </ul>
            </section>

            <section id="ms-risk">
                <h2>Multiple Sclerosis Risk</h2>

                <h3>Risk of Developing MS After Optic Neuritis</h3>
                <p>Based on ONTT and long-term follow-up studies:</p>

                <h4>Overall Risk</h4>
                <ul>
                    <li>~50% risk of developing MS within 15 years of isolated optic neuritis</li>
                </ul>

                <h4>Stratified by MRI Findings</h4>
                <ul>
                    <li><strong>Normal brain MRI (no lesions):</strong>
                        <ul>
                            <li>~25% risk at 15 years</li>
                            <li>Lower risk; isolated episode more likely</li>
                        </ul>
                    </li>
                    <li><strong>1 brain lesion:</strong> ~60% risk</li>
                    <li><strong>2+ brain lesions:</strong> ~70-80% risk at 15 years</li>
                </ul>

                <h3>MS Surveillance</h3>
                <ul>
                    <li>Neurologist follow-up, especially if brain lesions present</li>
                    <li>Monitor for new neurological symptoms</li>
                    <li>Repeat MRI may be done at intervals</li>
                    <li>Early MS treatment may be initiated if high risk</li>
                </ul>

                <h3>MS Symptoms to Watch For</h3>
                <ul>
                    <li>Numbness, tingling in limbs</li>
                    <li>Weakness</li>
                    <li>Balance problems, dizziness</li>
                    <li>Bladder issues</li>
                    <li>Fatigue</li>
                    <li>Cognitive changes</li>
                </ul>
            </section>

            <section id="recurrence">
                <h2>Recurrence</h2>

                <h3>Risk of Recurrent Optic Neuritis</h3>
                <ul>
                    <li>~30-35% experience recurrence (same or opposite eye) over 10 years</li>
                    <li>Higher if MS develops</li>
                    <li>Recurrences may be treated similarly (IV steroids)</li>
                    <li>Usually still recover, though cumulative damage may worsen outcomes</li>
                </ul>

                <h3>Chronic Relapsing Inflammatory Optic Neuropathy (CRION)</h3>
                <ul>
                    <li>Rare: Recurrent optic neuritis requiring chronic steroid or immunosuppressive therapy</li>
                    <li>Different from MS</li>
                </ul>
            </section>

            <section id="when-to-see">
                <h2>When to See a Doctor</h2>

                <div class="alert-box warning">
                    <h4><i class="fas fa-exclamation-triangle"></i> Seek Immediate Medical Attention If:</h4>
                    <ul>
                        <li><strong>Sudden vision loss in one eye</strong></li>
                        <li><strong>Eye pain with eye movement</strong></li>
                        <li><strong>Vision loss with colors appearing faded</strong></li>
                        <li><strong>Flashing lights with eye movement</strong></li>
                    </ul>
                    <p>Optic neuritis requires prompt evaluation. See ophthalmologist or go to emergency room,
                        especially if vision loss is significant.</p>
                </div>

                <h3>Follow-Up After Diagnosis</h3>
                <ul>
                    <li>Ophthalmology to monitor vision recovery</li>
                    <li>Neurology for MS risk assessment and surveillance</li>
                    <li>Regular neurological exams if MS suspected/diagnosed</li>
                </ul>

                <h3>Questions to Ask Your Doctor</h3>
                <ul>
                    <li>Do I have optic neuritis?</li>
                    <li>What caused it?</li>
                    <li>Do I need an MRI?</li>
                    <li>Are there brain lesions? What's my MS risk?</li>
                    <li>Should I get IV steroids?</li>
                    <li>What vision recovery can I expect?</li>
                    <li>Should I see a neurologist?</li>
                    <li>Do I need MS treatment?</li>
                    <li>What symptoms should I watch for?</li>
                </ul>
            </section>

            <div class="alert-box info">
                <h4><i class="fas fa-lightbulb"></i> Bottom Line</h4>
                <p>Optic neuritis is inflammation of the optic nerve causing sudden vision loss and eye pain with
                    movement, most commonly in young women ages 20-40. It's strongly associated with multiple
                    sclerosis—about half of patients with isolated optic neuritis will develop MS within 15 years,
                    especially if brain MRI shows white matter lesions. The good news is that vision typically recovers
                    substantially (90-95% achieve 20/40 or better), though subtle deficits may persist. IV
                    corticosteroids speed recovery but don't change final outcomes. If you experience sudden vision loss
                    with eye pain, seek immediate evaluation—brain MRI is critical to assess MS risk and guide long-term
                    management.</p>
            </div>

            <div class="related-diseases">
                <h3>Related Eye Conditions</h3>
                <div class="related-links">
                    <a href="papilledema.html">Papilledema</a>
                    <a href="ischemic-optic-neuropathy.html">Ischemic Optic Neuropathy</a>
                    <a href="uveitis.html">Uveitis</a>
                </div>
            </div>
        </main>
    </div>

    <footer>
        <div class="footer-content">
            <p>&copy; 2025 Vision Health Portal. All rights reserved.</p>
            <p class="designer-credit">Designed by RITIK DHAGE</p>
            <p style="font-size: 0.85rem; margin-top: 1rem; opacity: 0.8;">
                <i class="fas fa-info-circle"></i> This information is for educational purposes only and is not a
                substitute for professional medical advice, diagnosis, or treatment.
            </p>
        </div>
    </footer>
</body>

</html>